Collectins and pulmonary innate immunity.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 10719667)

Published in Immunol Rev on February 01, 2000

Authors

E Crouch1, K Hartshorn, I Ofek

Author Affiliations

1: Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA. crouch@path.wustl.edu

Articles citing this

C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 4.54

Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest (2003) 2.16

N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92

MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol (2009) 1.43

Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J (2000) 1.42

Surfactant protein-D and pulmonary host defense. Respir Res (2000) 1.41

Inhibition of major histocompatibility complex II expression and antigen processing in murine alveolar macrophages by Mycobacterium bovis BCG and the 19-kilodalton mycobacterial lipoprotein. Infect Immun (2004) 1.37

Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol (2004) 1.35

Alveolar surfactant protein D content modulates bleomycin-induced lung injury. Am J Respir Crit Care Med (2005) 1.28

Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol (2004) 1.25

Antimicrobial proteins and polypeptides in pulmonary innate defence. Respir Res (2006) 1.18

Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria. Infect Immun (2002) 1.11

Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun (2004) 1.09

Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med (2010) 1.09

Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J (2009) 1.05

Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci (Landmark Ed) (2012) 1.04

Pulmonary surfactant: a front line of lung host defense. J Clin Invest (2003) 1.03

Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem J (2006) 1.03

Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol (2007) 1.02

Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J Immunol (2009) 1.01

Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97

Distinctive anti-influenza properties of recombinant collectin 43. Biochem J (2002) 0.95

Biological activities of 'noninfectious' influenza A virus particles. Future Virol (2014) 0.95

Lack of the pattern recognition molecule mannose-binding lectin increases susceptibility to influenza A virus infection. BMC Immunol (2010) 0.93

Deleted in malignant brain tumors-1 protein (DMBT1): a pattern recognition receptor with multiple binding sites. Int J Mol Sci (2010) 0.92

Air pollution and epigenetics: effects on SP-A and innate host defence in the lung. Swiss Med Wkly (2012) 0.92

Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir Res (2009) 0.92

Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens. Infect Immun (2007) 0.92

Myeloperoxidase-dependent inactivation of surfactant protein D in vitro and in vivo. J Biol Chem (2010) 0.92

Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol (2006) 0.91

Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol (2010) 0.90

Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis. J Biol Chem (2012) 0.87

Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect Immun (2004) 0.85

Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change. J Biol Chem (2010) 0.85

Radiation-induced lung injury and inflammation in mice: role of inducible nitric oxide synthase and surfactant protein D. Toxicol Sci (2014) 0.84

Use of ex vivo and in vitro cultures of the human respiratory tract to study the tropism and host responses of highly pathogenic avian influenza A (H5N1) and other influenza viruses. Virus Res (2013) 0.83

Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. Infect Immun (2005) 0.83

Binding and agglutination of Streptococcus pneumoniae by human surfactant protein D (SP-D) vary between strains, but SP-D fails to enhance killing by neutrophils. Infect Immun (2004) 0.83

The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections. Ann Am Thorac Soc (2015) 0.81

Staphylococcus aureus proteases degrade lung surfactant protein A potentially impairing innate immunity of the lung. J Innate Immun (2012) 0.81

Lipid-restricted recognition of mycobacterial lipoglycans by human pulmonary surfactant protein A: a surface-plasmon-resonance study. Biochem J (2002) 0.81

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS One (2013) 0.80

Restoration of the normal Clara cell phenotype after chronic allergic inflammation. Int J Exp Pathol (2013) 0.80

Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2. J Proteom Genom Res (2013) 0.80

The battle between influenza and the innate immune response in the human respiratory tract. Infect Chemother (2013) 0.80

Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract. J Biol Chem (2012) 0.80

Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome. Am J Transplant (2013) 0.79

Genetic complexity of the human surfactant-associated proteins SP-A1 and SP-A2. Gene (2012) 0.78

Pulmonary surfactant protein a is expressed in mouse retina by Müller cells and impacts neovascularization in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2014) 0.78

Regulation of surfactant protein D in the rodent prostate. Reprod Biol Endocrinol (2007) 0.78

Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro. Philos Trans R Soc Lond B Biol Sci (2015) 0.77

Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein. Viruses (2013) 0.76

An overview of the synergy and crosstalk between pentraxins and collectins/ficolins: their functional relevance in complement activation. Exp Mol Med (2017) 0.75

Strains of Mycobacterium tuberculosis differ in affinity for human osteoblasts and alveolar cells in vitro. Springerplus (2016) 0.75

Articles by these authors

(truncated to the top 100)

Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature (1977) 10.17

Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99

Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55

Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30

Mannose residues on phagocytes as receptors for the attachment of Escherichia coli and Salmonella typhi. Biochem Biophys Res Commun (1977) 4.24

Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15

Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis (1979) 3.82

Isolation of a mannose-specific lectin from Escherichia coli and its role in the adherence of the bacteria to epithelial cells. Biochem Biophys Res Commun (1978) 3.62

Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc Natl Acad Sci U S A (1998) 3.04

Adherence of Acinetobacter calcoaceticus RAG-1 to human epithelial cells and to hexadecane. Infect Immun (1981) 2.74

Multiple adhesins of streptococci. Infect Immun (1992) 2.30

Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22

Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Escherichia coli. Biochem Biophys Res Commun (1982) 2.19

Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18

Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17

Carbohydrate specificity of the surface lectins of Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium. Carbohydr Res (1983) 2.14

Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. J Infect Dis (1988) 2.14

Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10

Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. J Infect Dis (1978) 2.02

Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00

Mannose-binding activity of Escherichia coli: a determinant of attachment and ingestion of the bacteria by macrophages. Infect Immun (1980) 1.98

Bacterial adherence. Adv Intern Med (1980) 1.80

Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75

Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. J Clin Microbiol (1991) 1.73

Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73

Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67

Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67

Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65

Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65

Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med (1991) 1.64

Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria. Infect Immun (1984) 1.63

Enzyme-linked immunosorbent assay for adherence of bacteria to animal cells. J Clin Microbiol (1986) 1.62

Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J Clin Microbiol (1989) 1.58

Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun (1986) 1.58

Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice. Infect Immun (1985) 1.55

Postnatal development of binding of streptococci and lipoteichoic acid by oral mucosal cells of humans. J Infect Dis (1977) 1.50

Influence of sublethal concentrations of antibiotics on the expression of the mannose-specific ligand of Escherichia coli. Infect Immun (1980) 1.49

Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine. Infect Immun (1981) 1.49

Lymphocytes binding and T cell mitogenic properties of group A streptococcal lipoteichoic acid. J Immunol (1979) 1.49

Bacterial adherence to cell surface sugars. Ciba Found Symp (1981) 1.47

Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli. Infect Immun (1991) 1.47

Interactions of fibronectin with streptococci: the role of fibronectin as a receptor for Streptococcus pyogenes. Rev Infect Dis (1988) 1.46

Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother (1989) 1.45

Growth advantage and enhanced toxicity of Escherichia coli adherent to tissue culture cells due to restricted diffusion of products secreted by the cells. J Clin Invest (1987) 1.45

Characterization of lipoteichoic acid binding to polymorphonuclear leukocytes of human blood. Infect Immun (1981) 1.43

Role of fibronectin in attachment of Streptococcus pyogenes and Escherichia coli to human cell lines and isolated oral epithelial cells. Infect Immun (1985) 1.41

Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun (1987) 1.41

Opsonic capacity of type specific streptococcal antibodies. Isr J Med Sci (1969) 1.35

Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun (1991) 1.34

Oxygen-stable hemolysins of group A streptococci. 8. Leukotoxic and antiphagocytic effects of streptolysins S and O. Infect Immun (1972) 1.32

Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein. J Exp Med (1979) 1.30

Membrane glycoproteins of human polymorphonuclear leukocytes that act as receptors for mannose-specific Escherichia coli. Infect Immun (1987) 1.29

Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae. Infect Immun (2000) 1.28

SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol (1997) 1.26

Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria. J Med Chem (2000) 1.25

Characteristics of the binding of streptococcal lipoteichoic acid to human oral epithelial cells. J Infect Dis (1980) 1.21

Cross-protection among serotypes of group A streptococci. J Infect Dis (1972) 1.20

Adherence of Candida albicans to human vaginal epithelial cells: inhibition by amino sugars. Exp Cell Biol (1982) 1.19

A high molecular mass constituent of cranberry juice inhibits helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol (2000) 1.17

Enhancement of mannose-mediated stimulation of human granulocytes by type 1 fimbriae aggregated with antibodies on Escherichia coli surfaces. Infect Immun (1983) 1.17

Safe as mother's milk: carbohydrates as future anti-adhesion drugs for bacterial diseases. Glycoconj J (2001) 1.16

Extended-spectrum beta-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother (2008) 1.16

N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity. Peptides (2001) 1.14

Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem (1996) 1.14

Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins. Infect Immun (1994) 1.13

Inhibition of blood clearance and hepatic tissue binding of Escherichia coli by liver lectin-specific sugars and glycoproteins. Infect Immun (1984) 1.13

Serologic diagnosis of streptococcal infection. Comparison of a rapid hemagglutination technique with conventional antibody tests. Am J Dis Child (1974) 1.12

Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2004) 1.11

Blastogenic responses of human lymphocytes to structurally defined polypeptide fragments of streptococcal M protein. J Immunol (1981) 1.09

Antibody tests in streptococcal pharyngitis. Streptozyme versus conventional methods. Clin Pediatr (Phila) (1973) 1.08

Identification of type specific streptococcal antibodies by in vitro phagocytosis. Isr J Med Sci (1969) 1.05

The functional association of polymyxin B with bacterial lipopolysaccharide is stereospecific: studies on polymyxin B nonapeptide. Biochemistry (2000) 1.05

Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect Immun (1994) 1.04

Human immunity to Neisseria gonorrhoeae: acquired serum opsonic antibodies. J Lab Clin Med (1975) 1.03

Fatty acid binding sites of serum albumin as membrane receptor analogs for streptococcal lipoteichoic acid. Infect Immun (1980) 1.03

Evaluation of streptozyme and antistreptolysin O tests in streptococcal pyodermal nephritis. Appl Microbiol (1973) 1.02

In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. J Antimicrob Chemother (2003) 1.02

Oxygen-stable hemolysins of group A streptococci. VII. The relation of the leukotoxic factor to streptolysin S. J Infect Dis (1970) 1.02

Rapid identification of Streptococcus pyogenes by flow cytometry. Eur J Clin Microbiol (1983) 1.02

Stimulation of oxidative burst in human monocytes by lipoteichoic acids. Infect Immun (1990) 1.01

Interaction of bacterial pili and leukocytes. Infection (1983) 1.00

Enzyme-linked immunosorbent assay for quantitation of attachment and ingestion stages of bacterial phagocytosis. J Clin Microbiol (1988) 0.99

Epidemic glomerulonephritis in Israel. J Infect Dis (1971) 0.99

Brief report: improvements in the behavior of children with autism following massage therapy. J Autism Dev Disord (2001) 0.98

Loss of lectin-like activity in aberrant type 1 fimbriae of Escherichia coli. Infect Immun (1981) 0.97

Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate). J Natl Cancer Inst (1976) 0.97

Type-specific streptococcal antibodies in pyodermal nephritis. J Infect Dis (1971) 0.95

The importance of mannose specific adhesins (lectins) in infections caused by Escherichia coli. Scand J Infect Dis Suppl (1982) 0.95

Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent [published erratam appear in J Am Dent Assoc 1999 Jan;130(1):36 and 1999 Mar;130(3):332]. J Am Dent Assoc (1998) 0.94

Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr (2008) 0.93

Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. FEMS Microbiol Lett (1999) 0.93

Effect of pH on in vitro phagocytosis of Streptococcus pyogenes. J Bacteriol (1969) 0.93

Hybridoma antibodies to the lipid-binding site(s) in the amino-terminal region of fibronectin inhibits binding of streptococcal lipoteichoic acid. J Infect Dis (1987) 0.92

Application of enzyme production properties in subtyping of group A streptococci according to T type. Appl Microbiol (1971) 0.91

M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells. FEMS Microbiol Lett (1997) 0.89

Sublethal concentrations of antibiotics and bacterial adhesion. Ciba Found Symp (1981) 0.89

Evaluation of micro complement fixation tests for antibodies against group A streptococcal M and M-associated antigens in rabbit and human sera. Appl Microbiol (1974) 0.86

Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res (2005) 0.86

Phagocytosis of Escherichia coli mediated by mannose resistant non-fimbrial haemagglutinin (NFA-1). Microb Pathog (1991) 0.85

Human plasma fibronectin inhibits adherence of Streptococcus pyogenes to hexadecane. Infect Immun (1985) 0.85